Yaya Sanni, Okonofua Friday, Ntoimo Lorretta, Kadio Bernard, Deuboue Rodrigue, Imongan Wilson, Balami Wapada
1School of International Development and Global Studies, University of Ottawa, Ottawa, Canada.
Women's Health and Action Research Centre, Benin City, Nigeria.
Glob Health Res Policy. 2018 Apr 4;3:12. doi: 10.1186/s41256-018-0066-y. eCollection 2018.
Nigeria presently has the second highest absolute number of maternal deaths and perinatal deaths (stillbirth and neonatal deaths) in the world. The country accounts for up to 14% of global maternal deaths and is second only to India in the number of women who die during childbirth. Although all parts of the country are worsened by these staggering statistics, several lines of evidence show that most maternal, and perinatal deaths occur in the north-east and north-west geo-political zones where women have limited access to evidence-based maternal and neonatal health services. The proposed project intends to identify the demand and supply factors that prevent women from using PHCs for maternal and early new-born care in Nigeria, and to test innovative and community relevant interventions for improving women's access to PHC services, and thus, ultimately, to prevent maternal and perinatal deaths.
An open-labelled, randomized controlled trial will is carried out in two local government areas selected based on three criteria (i) maternal mortality rates (ii) PHC utilization rates and (iii) and geographic localization. The study will be conducted over 54-months in six communities, with PHCs in six communities of similar status serving as control sites. Surveys about quality of care and maternal health services utilization will be carried out at baseline, at midterm and at end of the project to test the effectiveness of the intervention, alongside conventional epidemiological measures of maternal and perinatal mortality. Ethical approval for the study has been granted (reference no. NHREC/01/01/2007). The findings will be published in compliance with reporting guidelines for randomized controlled trials.
The current Federal Government in Nigeria has identified PHC as its main strategy for increasing access to health in Nigeria. However, despite numerous efforts, there are persisting concerns that there is currently no scientific evidence on which to base the improvement of PHCs. The results of this study will identify barriers in the use of PHCs and will provide scientific evidence for effective and innovative interventions for improving PHCs that can be rolled out throughout the country.
Clinical Trials.gov NCT02643953.
尼日利亚目前是全球孕产妇死亡及围产期死亡(死产和新生儿死亡)绝对数量第二高的国家。该国占全球孕产妇死亡人数的14%,在分娩期间死亡的妇女人数仅次于印度。尽管该国所有地区都受到这些惊人统计数据的影响,但有几条证据表明,大多数孕产妇和围产期死亡发生在东北和西北地缘政治区,那里的妇女获得循证孕产妇和新生儿保健服务的机会有限。拟议的项目旨在确定阻碍尼日利亚妇女利用初级卫生保健机构提供孕产妇和新生儿早期护理的需求和供应因素,并测试创新且与社区相关的干预措施,以改善妇女获得初级卫生保健服务的机会,从而最终预防孕产妇和围产期死亡。
将根据三项标准(i)孕产妇死亡率、(ii)初级卫生保健利用率和(iii)地理位置,在两个地方政府辖区开展一项开放标签的随机对照试验。该研究将在六个社区进行54个月,六个状况类似社区的初级卫生保健机构作为对照点。在基线期、中期和项目结束时,将开展关于护理质量和孕产妇保健服务利用情况的调查,以测试干预措施的有效性,同时采用孕产妇和围产期死亡率的常规流行病学指标。该研究已获得伦理批准(参考编号NHREC/01/01/2007)。研究结果将按照随机对照试验的报告指南予以发表。
尼日利亚现任联邦政府已将初级卫生保健确定为增加该国卫生服务可及性的主要战略。然而,尽管付出了诸多努力,但人们一直担心目前没有科学证据作为改善初级卫生保健机构的依据。本研究结果将确定初级卫生保健机构使用方面的障碍,并为可在全国推广的有效且创新的初级卫生保健改善干预措施提供科学证据。
ClinicalTrials.gov NCT02643953